Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 126.23
+4.04 (3.31%)
Sep 30, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 6.86 billion as of September 30, 2026. Its market cap has increased by 54.18% in one year.
Market Cap
6.86B
Enterprise Value
6.99B
Revenue
3.06B
Ranking
n/a
PE Ratio
42.81
Stock Price
126.23
ChartMarket Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 6.86B, a decrease of -7.32%. That is a compound annual growth rate of -2.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 6.86B | 80.33% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 24.96B |
| Indoco Remedies | 24.84B |
| Windlas Biotech | 22.62B |
| Beta Drugs | 20.93B |
| Anlon Healthcare | 18.38B |
| Jagsonpal Pharmaceuticals | 15.67B |
| Sigachi Industries | 10.99B |
| Bafna Pharmaceuticals | 8.61B |